Targeting of therapeutics to the liver: Liposomes and viral vectors

C. Di Campli, J. Wu, Mark A Zern

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

A successful strategy for the treatment of hepatic damage should be based on the use of nontoxic drugs with a high therapeutic index and safety profile, as well as selective targeting delivery. To achieve these goals, several biological and synthetic vehicles have been formulated with a wide range of chemical and physical properties. These vectors allow the delivery of either traditional drugs or genetic material to the cells. Despite remarkable progress, the design of an ideal carrier is still to be accomplished. Safety issues concerning viral vectors and low efficiency of synthetic delivery systems are the main limitations of present vectors. Once these problems are overcome, the liver-specific targeting systems will provide new opportunities to treat a vast range of hepatic diseases.

Original languageEnglish (US)
Pages (from-to)950-954
Number of pages5
JournalAlcoholism: Clinical and Experimental Research
Volume23
Issue number5
StatePublished - May 1999
Externally publishedYes

Fingerprint

Liposomes
Liver
Safety
Pharmaceutical Preparations
Chemical properties
Therapeutics
Physical properties
Genes

Keywords

  • Drug Delivery
  • Gene Therapy
  • Liposomes
  • Liver Diseases
  • SV-40

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Toxicology

Cite this

Targeting of therapeutics to the liver : Liposomes and viral vectors. / Di Campli, C.; Wu, J.; Zern, Mark A.

In: Alcoholism: Clinical and Experimental Research, Vol. 23, No. 5, 05.1999, p. 950-954.

Research output: Contribution to journalArticle

Di Campli, C. ; Wu, J. ; Zern, Mark A. / Targeting of therapeutics to the liver : Liposomes and viral vectors. In: Alcoholism: Clinical and Experimental Research. 1999 ; Vol. 23, No. 5. pp. 950-954.
@article{a1769c1dadc948bfa25a32c0539fcbe3,
title = "Targeting of therapeutics to the liver: Liposomes and viral vectors",
abstract = "A successful strategy for the treatment of hepatic damage should be based on the use of nontoxic drugs with a high therapeutic index and safety profile, as well as selective targeting delivery. To achieve these goals, several biological and synthetic vehicles have been formulated with a wide range of chemical and physical properties. These vectors allow the delivery of either traditional drugs or genetic material to the cells. Despite remarkable progress, the design of an ideal carrier is still to be accomplished. Safety issues concerning viral vectors and low efficiency of synthetic delivery systems are the main limitations of present vectors. Once these problems are overcome, the liver-specific targeting systems will provide new opportunities to treat a vast range of hepatic diseases.",
keywords = "Drug Delivery, Gene Therapy, Liposomes, Liver Diseases, SV-40",
author = "{Di Campli}, C. and J. Wu and Zern, {Mark A}",
year = "1999",
month = "5",
language = "English (US)",
volume = "23",
pages = "950--954",
journal = "Alcoholism: Clinical and Experimental Research",
issn = "0145-6008",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Targeting of therapeutics to the liver

T2 - Liposomes and viral vectors

AU - Di Campli, C.

AU - Wu, J.

AU - Zern, Mark A

PY - 1999/5

Y1 - 1999/5

N2 - A successful strategy for the treatment of hepatic damage should be based on the use of nontoxic drugs with a high therapeutic index and safety profile, as well as selective targeting delivery. To achieve these goals, several biological and synthetic vehicles have been formulated with a wide range of chemical and physical properties. These vectors allow the delivery of either traditional drugs or genetic material to the cells. Despite remarkable progress, the design of an ideal carrier is still to be accomplished. Safety issues concerning viral vectors and low efficiency of synthetic delivery systems are the main limitations of present vectors. Once these problems are overcome, the liver-specific targeting systems will provide new opportunities to treat a vast range of hepatic diseases.

AB - A successful strategy for the treatment of hepatic damage should be based on the use of nontoxic drugs with a high therapeutic index and safety profile, as well as selective targeting delivery. To achieve these goals, several biological and synthetic vehicles have been formulated with a wide range of chemical and physical properties. These vectors allow the delivery of either traditional drugs or genetic material to the cells. Despite remarkable progress, the design of an ideal carrier is still to be accomplished. Safety issues concerning viral vectors and low efficiency of synthetic delivery systems are the main limitations of present vectors. Once these problems are overcome, the liver-specific targeting systems will provide new opportunities to treat a vast range of hepatic diseases.

KW - Drug Delivery

KW - Gene Therapy

KW - Liposomes

KW - Liver Diseases

KW - SV-40

UR - http://www.scopus.com/inward/record.url?scp=0032994427&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032994427&partnerID=8YFLogxK

M3 - Article

C2 - 10371421

AN - SCOPUS:0032994427

VL - 23

SP - 950

EP - 954

JO - Alcoholism: Clinical and Experimental Research

JF - Alcoholism: Clinical and Experimental Research

SN - 0145-6008

IS - 5

ER -